Literature DB >> 24857820

FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury.

Shi Jia1, Zhenzhen Chen1, Jing Li2, Yujing Chi3, Jinyu Wang1, Sha Li1, Yanjin Luo1, Bin Geng1, Cheng Wang1, Qinghua Cui1, Youfei Guan1, Jichun Yang4.   

Abstract

The biological function of FAM3A, the first member of family with sequence similarity 3 (FAM3) gene family, remains largely unknown. This study aimed to determine its role in the proliferation and migration of vascular smooth muscle cells (VSMCs). Immunohistochemical staining revealed that FAM3A protein is expressed in the tunica media of rodent arteries, and its expression is reduced with an increase in prostaglandin E receptor 2 (EP2) expression after injury. In vitro, FAM3A overexpression promotes proliferation and migration of VSMCs, whereas FAM3A silencing inhibits these processes. In vivo, FAM3A overexpression results in exaggerated neointima formation of rat carotid artery after balloon injury. FAM3A activates Akt in a PI3K-dependent manner. In contrast, FAM3A induces ERK1/2 activation independent of PI3K. FAM3A protein is subcellularly located in mitochondria, where it affects ATP production and release. Activation of EP2 represses FAM3A expression, leading to impaired ATP production and release in VSMCs. FAM3A-induced activation of Akt and ERK1/2 pathways, proliferation and migration of VSMCs are inhibited by P2 receptor antagonist suramin. Furthermore, inhibition or knockdown of P2Y1 receptor inihibits FAM3A-induced proliferation and migration of VSMCs. In conclusion, FAM3A promotes proliferation and migration of VSMCs via P2Y1 receptor-mediated activation of Akt and ERK1/2 pathways. In injured vessels, FAM3A was repressed by upregulated EP2 expression, leading to the attenuation of ATP-P2Y1 receptor signaling, which is beneficial for preventing excessive proliferation and migration of VSMCs.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EP2; FAM3A; P2Y receptor; Proliferation; VSMCs

Mesh:

Substances:

Year:  2014        PMID: 24857820     DOI: 10.1016/j.yjmcc.2014.05.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

Review 1.  Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver.

Authors:  Weili Yang; Ji Chen; Yuhong Meng; Zhenzhen Chen; Jichun Yang
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

2.  Repurposing Doxepin to Ameliorate Steatosis and Hyperglycemia by Activating FAM3A Signaling Pathway.

Authors:  Zhenzhen Chen; Xiangyang Liu; Yanjin Luo; Junpei Wang; Yuhong Meng; Lei Sun; Yongsheng Chang; Qinghua Cui; Jichun Yang
Journal:  Diabetes       Date:  2020-04-20       Impact factor: 9.461

3.  The Stat3-Fam3a axis promotes muscle stem cell myogenic lineage progression by inducing mitochondrial respiration.

Authors:  David Sala; Thomas J Cunningham; Michael J Stec; Usue Etxaniz; Chiara Nicoletti; Alessandra Dall'Agnese; Pier Lorenzo Puri; Gregg Duester; Lucia Latella; Alessandra Sacco
Journal:  Nat Commun       Date:  2019-04-17       Impact factor: 14.919

4.  FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1.

Authors:  Weili Yang; Biaoqi Feng; Yuhong Meng; Junpei Wang; Bin Geng; Qinghua Cui; Hongquan Zhang; Yang Yang; Jichun Yang
Journal:  J Cell Mol Med       Date:  2019-03-19       Impact factor: 5.310

5.  Intracellular ATP Signaling Contributes to FAM3A-Induced PDX1 Upregulation in Pancreatic Beta Cells.

Authors:  Han Yan; Zhenzhen Chen; Haizeng Zhang; Weili Yang; Xiangyang Liu; Yuhong Meng; Rui Xiang; Zhe Wu; Jingjing Ye; Yujing Chi; Jichun Yang
Journal:  Exp Clin Endocrinol Diabetes       Date:  2021-09-30       Impact factor: 2.426

Review 6.  Link between sterile inflammation and cardiovascular diseases: Focus on cGAS-STING pathway in the pathogenesis and therapeutic prospect.

Authors:  Yao Du; Hui Zhang; Xiaoyan Nie; Yajun Qi; Shi Shi; Yingying Han; Wenchen Zhou; Chaoyong He; Lintao Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-22

7.  The apolipoprotein A-I mimetic peptide, D-4F, restrains neointimal formation through heme oxygenase-1 up-regulation.

Authors:  Donghui Liu; Mengzhang Wu; Qian Du; Zhenzhen Ding; Mingming Qian; Zijia Tong; Wenqi Xu; Le Zhang; He Chang; Yan Wang; Caihua Huang; Donghai Lin
Journal:  J Cell Mol Med       Date:  2017-08-02       Impact factor: 5.310

8.  FAM3A enhances adipogenesis of 3T3-L1 preadipocytes via activation of ATP-P2 receptor-Akt signaling pathway.

Authors:  Yujing Chi; Jing Li; Na Li; Zhenzhen Chen; Liping Ma; Weikang Peng; Xiuying Pan; Mei Li; Weidong Yu; Xiangjun He; Bin Geng; Qinghua Cui; Yulan Liu; Jichun Yang
Journal:  Oncotarget       Date:  2017-07-11

9.  FAM3A mediates PPARγ's protection in liver ischemia-reperfusion injury by activating Akt survival pathway and repressing inflammation and oxidative stress.

Authors:  Zhenzhen Chen; Junpei Wang; Weili Yang; Ji Chen; Yuhong Meng; Bin Geng; Qinghua Cui; Jichun Yang
Journal:  Oncotarget       Date:  2017-07-25

10.  Defining Essentiality Score of Protein-Coding Genes and Long Noncoding RNAs.

Authors:  Pan Zeng; Ji Chen; Yuhong Meng; Yuan Zhou; Jichun Yang; Qinghua Cui
Journal:  Front Genet       Date:  2018-10-09       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.